US FDA requests 23% increase in funds for FY 2011
This article was originally published in RAJ Devices
The US Food and Drug Administration has requested funds totalling over $4 billion for fiscal year 20111,2. The request represents a 23% increase over the FY 2010 budget, when the FDA received around $3.28 billion3.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.